Cornea and External Disease

Triple therapy reduces corneal graft rejection after high-risk keratoplasty

Combining systemic mycophenolate mofetil (MMF) with topical tacrolimus (FK506) and corticosteroid eyedrops significantly reduces the risk of corneal graft rejection and improves graft survival rates in patients undergoing high-risk keratoplasty (HRK), compared to using FK506 and corticosteroids alone, according to a study. The study included 55 patients with HRK, characterized...